Recent Advances in Classical Hematology

Indy Hematology Review

R. Brodsky

Bone Marrow Failure: The Importance of Mutational Testing

Rush University Medical Center

J. Shammo

Highlights From ASH 2023 in Bone Marrow Failure Disorders: Aplastic …

Insights from 2023 ASH Annual Meeting

P. Scheinberg

Severe Aplastic Anemia: What's on the Horizon?

Johns Hopkins

A. DeZern

Managing Hematologic irAEs: AIHA, ITP, Bone Marrow Failure, and Thro…

Cleveland Clinic Taussig Cancer Institute

K. McCrae

ASH Annual Meeting Updates in Non-Malignant/Classical Hematology

UChicago Medicine

K. Cohen

AA & PNH Case Discussion: 23 y/o Female With PNH With Clonal Regress…

BMFcases

J. Maciejewski, T. Bat

AA & PNH Case Discussion: 53 y/o Male With PNH and Severe AA

BMFcases

J. Maciejewski, T. Bat

Severe Aplastic Anemia: Current Challenges

Taha Bat

Future Perspectives on Aplastic Anemia

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

R. de Latour

Hematology Case Discussion: 71 y/o Female With R/R Aplastic Anemia a…

BMFcases

C. Dunbar, T. Bat

Hematology Case Discussion: 67 y/o Male With Severe Aplastic Anemia …

BMFcases

C. Dunbar, T. Bat

Case Presentation: 46 y/o Male With Severe Aplastic Anemia

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A. Mert Yanık

Curative Therapies for Pediatric Acquired Aplastic Anemia

Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

T. Olson

ASH 2022 New Biological Insights on Clonal Evolution in Aplastic Ane…

ASH 2022 Conference Coverage

A. Kulasekararaj

Aplastic Anemia: A Brief Review

Lucio Luzzatto

Managing Hematologic Toxicities From Immunotherapeutic Agents

Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies

M. Jaglal

Importance of Supportive Care in Severe Aplastic Anemia

Phillip Scheinberg

Immunosuppressive Therapy in Aplastic Anemia

Abhinav Deol

Frontline Therapy for Aplastic Anemia in Transplant-Ineligible Patie…

Tapan Kadia